Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Sales6848841 0521 0841 1651 296
EBITDA161231289291319362
Operating profit (EBIT)120185226239262298
Pre-Tax Profit (EBT)105170213234268317
Net income72,5139177165179206
P/E ratio34,239,031,236,432,227,5
EPS ( € )0,791,511,921,771,992,34
Dividend per Share ( € )0,220,330,420,400,600,56
Yield0,81%0,56%0,70%0,62%0,93%0,87%
Reference price ( € )26.883358.959.9764.2564.2564.25
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Debt87,486,459,010610563,5
Finance------
Operating income (EBITDA)161231289291319362
Leverage
(Debt/EBITDA)
0,54x0,37x0,20x0,36x0,33x0,18x
Capital Expenditure47,153,079,7116108105
Book Value Per Share (BVPS)5,78 €6,96 €8,22 €9,63 €11,2 €13,1 €
Cash Flow per Share1,21 €1,52 €1,70 €2,25 €2,51 €2,80 €
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 5 923 M€ -
Entreprise Value (EV) 6 028 M€ 6 027 M€
Valuation 2017e 2018e
P/E ratio (Price / EPS) 36,4x 32,2x
Capitalization / Revenue 5,46x 5,08x
EV / Revenue 5,56x 5,17x
EV / EBITDA 20,7x 18,9x
Yield (DPS / Price) 0,62% 0,93%
Price to book (Price / BVPS) 6,67x 5,73x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 22,0% 22,5%
operating Leverage (Delta EBIT / Delta Sales) 1,80x 1,34x
Net Margin (Net Profit / Revenue) 15,3% 15,4%
ROA (Net Profit / Asset) 11,3% 11,1%
ROE (Net Profit / Equities) 19,4% 18,0%
Rate of Dividend 22,6% 30,0%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   10,7% 9,29%
Cash Flow / Sales 19,1% 19,8%
Capital Intensity (Assets / Sales) 1,35x 1,39x
Financial Leverage (Net Debt / EBITDA) 0,36x 0,33x
EPS & Dividend